Aether Therapeutics Inc. v. RedHill Biopharma Inc.
1:21-cv-00248
Overview
Parties
Defendant
RedHill Biopharma Inc. Operating Company
Represented By
8 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Plaintiff
Aether Therapeutics Inc. Operating Company
Represented By
8 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Stamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 6,713,488 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 18,937,200 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2001004937 | US Continuation / Sibling | View Official Patent → |
Aether Therapeutics Inc. v. AstraZeneca AB
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6713488
Neutral antagonists and use thereof in treating drug abuse
|
Filed: 2002-06-14
Issued: 2004-03-30
|
Expired (Term Ended)
Expires: 2022-06-14
|
|
|
US8748448
Combination analgesic employing opioid agonist and neutral antagonist
|
Filed: 2012-11-28
Issued: 2014-06-10
|
Active (6.0 yrs remaining)
Expires: 2032-11-28
|
|
|
US8883817
Combination analgesic employing opioid and neutral antagonist
|
Filed: 2008-10-17
Issued: 2014-11-11
|
Active (4.5 yrs remaining)
+943d PTA
Expires: 2031-05-18
|
|
|
US9061024
Combination analgesic employing opioid agonist and neutral antagonist
|
Filed: 2014-05-15
Issued: 2015-06-23
|
Active (7.5 yrs remaining)
Expires: 2034-05-15
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
71
Dispositive
10
Granted
5
Denied
0
Pending / Review
50
Motions by Category
Key Dispositive Motions & Rulings